3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neurofibromatosis 1
1
Interventions
AZD 6244
7
trametinib
2
omipalisib
1
mirdametinib
1
Vincristine
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Lovastatin
1
Dosage Forms
1
Curcumin
1
Control Groups
1
Carboplatin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neurofibromatosis 1
×
Dosage Forms
×
Clear all
NCT05309668
2025-12-18
SPRINKLE
AstraZeneca
Phase 1/2
Active not recruiting
36 enrolled
37 charts